Good mental health associated with excellent adherence among people taking ART for prevention
Cabotegravir and rilpivirine effective for HIV maintenance therapy at 96 weeks
Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people
We may need to combine many approaches to achieve a cure, delegates hear
Does HIV make you fat? Study connects viral load with fat gains
HIV attachment inhibitor BMS-663068 safe and effective in phase 2b study
Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease
Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation
HIV maturation inhibitor BMS-955176 looks promising in early study
